Advertisement

Search Results

Advertisement

Your search for Julie A. Schneider, PhD,Julie A. Schneider, PhD matches 2 pages

Showing 1 - 2

Advertisement

issues in oncology

By Julie A. Schneider, PhD; Jennifer J. Gao, MD; Martha B. Donoghue, MD; Lola Fashoyin-Aje, MD, MPH; Jeff Summers, MD; Paul G. Kluetz, MD; Marc R. Theoret, MD; and Richard Pazdur, MD / February 10, 2023

FDA Oncology Center of Excellence Seeks Applications for New Research Funding Opportunities

OCE Insights is an occasional column developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this installment, Julie A. Schneider, PhD, Associate Director for Research Strategy and Partnerships, OCE; Jennifer J. Gao, MD,...

By Julie A. Schneider, PhD; Jennifer J. Gao, MD; Donna R. Rivera, PharmD, MS; Martha B. Donoghue, MD; Gregory H. Reaman, MD, FASCO, Associate Director for Pediatric Oncology, OCE; Rajeshwari Sridhara, PhD; Julia A. Beaver, MD; Paul G. Kluetz, MD; Marc R. Theoret, MD; and Richard Pazdur, MD / December 25, 2021

The Oncology Center of Excellence Encourages Submissions of Applied Regulatory Science Research Proposals

OCE Insights is an occasional column developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this installment, Julie A. Schneider, PhD, Associate Director for Research Strategy and Partnerships, OCE; Jennifer J. Gao, MD,...

Advertisement

Advertisement

Nov

21

Today In Oncology

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors

Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC

Advertisement

© 2024 HSP News Service, L.L.C.